Platelet aggregation evaluated with microchip flow-chamber system in patients with acute coronary syndromes.

Platelet aggregation evaluated with microchip flow-chamber system in patients with acute coronary syndromes. - PLATE-ACS

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024280

Enrollment

Registered

2016-12-01

Start date

2015-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndromes

Interventions

Patients with ACS were randomly assigned to clopidogrel (loading/maintenance dose: 300/75 mg) or prasugrel (20/3.75 mg). Aspirin (200/100 mg) was administered in both groups. We evaluated the platelet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute coronary syndromes; ST segment elevation myocardial infarction, non-ST elevation myocardial infarction and unstable angina pectoris

Exclusion criteria

Exclusion criteria: 1. Indication for emergent CABG 2. Patients who are pregnant 3. Patients with past history of HIT 4. Other

Design outcomes

Primary

Measure	Time frame
T10(time to 10kPa from baseline) and AUC10(area under the flow pressure curve for the first 10 min)	—

Secondary

Measure	Time frame
MACE:Major Adverse Cardiovascular Events, and hemorrhage	—

Countries

Japan

Contacts

Public ContactToshiki Asada

Yokohama Sakae Kyosai Hospital Cardiology

toshiki_asada@hotmail.com+81458912171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026